VAERS reports by lot

GSK DTaP/Tdap lot 54B74: VAERS reports

25 VAERS reports list lot 54B74 as a GSK DTaP/Tdap vaccine, received between 2018-05-12 and 2020-02-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
20%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1419%
Neurological1317%
General / Systemic (non-local)1317%
Musculoskeletal1115%
Cardiac / Cardiovascular79%
Allergic / Anaphylactic68%
Dermatological (non-injection-site)57%
Respiratory34%
Gastrointestinal23%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey3
North Carolina3
Virginia3
California2
Illinois2
Alaska1
Colorado1
New York1
Minnesota1
Montana1
Florida1
Arizona1

Reports by month received

2018-053
2018-064
2018-075
2018-086
2018-092
2018-101
2018-122
2019-061
2020-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.